\ ALS Research \ Neuromuscular Research Partnership 2007 Recipients
University of Toronto/University Health Network
“Interplay of oxidative stress and protein misfolding in ALS”
Three years
Stephen Gee, PhD
University of Ottawa
“Investigating the role of diacylglycerol kinase zeta in the assembly and maintenance of the myofibrillar apparatus in skeletal muscle”
Three years
Anthony Gramolini, PhD
University of Toronto
“Molecular basis of ryanodine receptor regulation and function in skeletal muscle”
Five years
Paul Holland, PhD and Josephine Nalbantoglu, PhD
McGill University/Montreal Neurological Institute
“Combinatorial use of viral vectors for the gene therapy of muscle”
Two years
Jiming Kong, PhD
University of Manitoba
“ALS: rescue of mutant SOD1-induced motor neuron death by targeting the BNIP3 death gene family”
One year
Jasna Kriz, MD, PhD
Université Laval
“Live imaging and analysis of disease onset and progression in ALS”
Three years
Guy Rouleau, MD, PhD
Centre Hospitalier de l’Université de Montreal
“Characterization of PABPN1 for the development of an oculopharyngeal muscular dystrophy (OPMD) treatment”
Three years
Michael Sinnreich, PhD
McGill University
“Development of therapeutic strategies for dysferlin deficiency”
Three years
Stefano Stifani, PhD
McGill University
“Motor neuron differentiation, connectivity and regeneration”
Four years
Tanja Taivassalo, PhD
McGill University
“Exercise-induced upregulation of mitochondrial gene expression: therapeutic strategies for mitochondrial disease”
Three years
Jacques Tremblay, MD, PhD
Université Laval
“Improving MPC transplantation by increasing IGF-1 or MGF stimulation”
Three years
Christine Vande Velde, PhD
Université de Montreal
“Identification of the mechanisms of motor neuron degeneration in ALS”
Three years
|
|
Click Here For A Printer Friendly Version Of This Page
Neuromuscular Research Partnership 2007 Recipients
Avijit Chakrabartty, PhDUniversity of Toronto/University Health Network
“Interplay of oxidative stress and protein misfolding in ALS”
Three years
Stephen Gee, PhD
University of Ottawa
“Investigating the role of diacylglycerol kinase zeta in the assembly and maintenance of the myofibrillar apparatus in skeletal muscle”
Three years
Anthony Gramolini, PhD
University of Toronto
“Molecular basis of ryanodine receptor regulation and function in skeletal muscle”
Five years
Paul Holland, PhD and Josephine Nalbantoglu, PhD
McGill University/Montreal Neurological Institute
“Combinatorial use of viral vectors for the gene therapy of muscle”
Two years
Jiming Kong, PhD
University of Manitoba
“ALS: rescue of mutant SOD1-induced motor neuron death by targeting the BNIP3 death gene family”
One year
Jasna Kriz, MD, PhD
Université Laval
“Live imaging and analysis of disease onset and progression in ALS”
Three years
Guy Rouleau, MD, PhD
Centre Hospitalier de l’Université de Montreal
“Characterization of PABPN1 for the development of an oculopharyngeal muscular dystrophy (OPMD) treatment”
Three years
Michael Sinnreich, PhD
McGill University
“Development of therapeutic strategies for dysferlin deficiency”
Three years
Stefano Stifani, PhD
McGill University
“Motor neuron differentiation, connectivity and regeneration”
Four years
Tanja Taivassalo, PhD
McGill University
“Exercise-induced upregulation of mitochondrial gene expression: therapeutic strategies for mitochondrial disease”
Three years
Jacques Tremblay, MD, PhD
Université Laval
“Improving MPC transplantation by increasing IGF-1 or MGF stimulation”
Three years
Christine Vande Velde, PhD
Université de Montreal
“Identification of the mechanisms of motor neuron degeneration in ALS”
Three years
| Posted On: Thursday, December 06, 2007 Modified: Thursday, December 06, 2007 Category: ALS Research Posted By: |